GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Entourage Health Corp (TSXV:ENTG) » Definitions » Cash Ratio

Entourage Health (TSXV:ENTG) Cash Ratio : 0.02 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Entourage Health Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Entourage Health's Cash Ratio for the quarter that ended in Sep. 2024 was 0.02.

Entourage Health has a Cash Ratio of 0.02. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Entourage Health's Cash Ratio or its related term are showing as below:

TSXV:ENTG' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.86   Max: 86.88
Current: 0.02

During the past 10 years, Entourage Health's highest Cash Ratio was 86.88. The lowest was 0.01. And the median was 0.86.

TSXV:ENTG's Cash Ratio is ranked worse than
94.52% of 1004 companies
in the Drug Manufacturers industry
Industry Median: 0.585 vs TSXV:ENTG: 0.02

Entourage Health Cash Ratio Historical Data

The historical data trend for Entourage Health's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entourage Health Cash Ratio Chart

Entourage Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 1.04 0.18 0.06 0.06

Entourage Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.05 0.01 0.02

Competitive Comparison of Entourage Health's Cash Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Entourage Health's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entourage Health's Cash Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Entourage Health's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Entourage Health's Cash Ratio falls into.



Entourage Health Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Entourage Health's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=11.154/172.315
=0.06

Entourage Health's Cash Ratio for the quarter that ended in Sep. 2024 is calculated as:

Cash Ratio (Q: Sep. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=3.519/190.086
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entourage Health  (TSXV:ENTG) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Entourage Health Cash Ratio Related Terms

Thank you for viewing the detailed overview of Entourage Health's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Entourage Health Business Description

Traded in Other Exchanges
Address
250 Elm Street, Aylmer, ON, CAN, N5H 2M8
Entourage Health Corp is a licence holder producing and distributing cannabis products for both the medical and adult-use markets. It owns and operates greenhouse, outdoor, and processing facility located in Strathroy as well as a fully licensed Aylmer processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, it has expanded its multi-channeled distribution. The company operates in one segment, the production and sale of cannabis in Canada.
Executives
George Scorsis Director, Senior Officer
James Afara Senior Officer
Vincent Doré Senior Officer